Lanz Michael, Happe Svenja
Abteilung für Klinische Neurophysiologie, Klinikum Bremen-Ost.
MMW Fortschr Med. 2007 May 21;149 Suppl 2:42-4.
The restless legs syndrome (RLS) is a frequently occurring neurological disease that is often associated with sleep disorders and reduced quality of life. The cause of RLS still has not been clearly established; however, the dopaminergic and opioid systems and iron metabolism appear to have major roles in the disease. The therapy of choice is treatment with dopaminergic drugs. In addition, opiates and anticonvulsants such as gabapentin are used. The most important side effect of dopaminergic therapy is augmentation. If therapy-related augmentation occurs while taking levodopa, the medication should be changed to dopamine agonists. If augmentation occurs while taking dopamine agonists, opiates or gabapentin should be taken instead.
不安腿综合征(RLS)是一种常见的神经系统疾病,常与睡眠障碍和生活质量下降相关。RLS的病因尚未明确;然而,多巴胺能和阿片系统以及铁代谢似乎在该疾病中起主要作用。首选治疗方法是使用多巴胺能药物进行治疗。此外,还使用阿片类药物和抗惊厥药,如加巴喷丁。多巴胺能治疗最重要的副作用是症状加重。如果在服用左旋多巴时出现与治疗相关的症状加重,应将药物更换为多巴胺激动剂。如果在服用多巴胺激动剂时出现症状加重,则应改用阿片类药物或加巴喷丁。